Navigation Links
Advanced Life Sciences Announces Fourth Quarter and Full Year 2007 Financial Results
Date:2/19/2008

development expense. Total research and development

expense increased $8.5 million to approximately $25.7 million for the

twelve months ended December 31, 2007 from approximately $17.2 million

for the twelve months ended December 31, 2006. The increase in R&D

expense is related to clinical trials and manufacturing costs

associated with the Company's lead product, cethromycin.

-- General and administrative expense. General and administrative

expense increased $1.4 million to $6.8 million for the twelve months

ended December 31, 2007. Salary and benefit expense increased

$944,000 and was comprised of $614,000 of incremental salary and

benefit expense and $330,000 in non-cash compensation expense related

to stock option issuances. Marketing expenses related to the branding

of cethromycin increased $235,000 over 2006, the result of a larger

presence at key scientific meetings throughout the year. Facilities

expense increased $143,000 as compared to 2006 which resulted from our

facilities expansion that was completed during the fourth quarter of

2006.

Fourth Quarter Expense Analysis: 2007 versus 2006:

-- Research and development expense. Total research and development

expense decreased $1.6 million to approximately $4.0 million for the

three months ended December 31, 2007 from approximately $5.6 million

for the three months ended December 31, 2006. The decrease in R&D

expense reflects decreased development expenses associated with the

completion of community acquired pneumonia clinical trials for

cethromycin.

-- General and administrative expense. General and administrative

expense remained at $1.5 million for the three months ended

December 31, 2007 as it had in the three months ended

December 31,
'/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
3. Advanced Cell Technology Announces Proposed Financing
4. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
5. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
6. Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference
7. CeloNova BioSciences Announces Worlds First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres
8. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
9. Advanced Bionics Deploys CEVA-TeakLite(TM) DSP Core to Enhance Its Harmony(TM) HiResolution(R) Bionic Ear System
10. NIH Announces Advanced Cell Technologys Single Cell Embryo Biopsy Technique as a Means to Derive Embryonic Stem Cells to be Considered for Federal Funding
11. Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... Cellgen Diagnostics today launched ... a corporate lab for its genetic-based medical testing ... a critical component in the move from today’s ... of personalized medicine – a more predictive, preventive, ... contributions will support Cellgen’s intent to develop the ...
(Date:8/19/2014)... Robin Williams’ passing is a sad reminder ... individual. Symptoms range from slowness of voluntary movements ... severe depression. Parkinson’s disease progressively gets worse over ... neurons of the brain. As these patients struggle ... progressively gets worse, they look for options. ...
(Date:8/19/2014)... Research and Markets ... "Spectroscopy Equipment and Accessories - Global Strategic ... This report analyzes the ... in US$ Thousands by the following Product ... NMR-EPR Spectrometers, Near Infrared (NIR) Spectrometers, IR ...
(Date:8/19/2014)... November 2012, the European Union (EU) mandated use of the ... PSUR – responding to the increasing need to understand and ... in many regions, the main objectives of the PBRER are ... analysis of new or emerging information on the risks of ... the potential benefits of a drug; and , ...
Breaking Biology Technology:Cellgen Diagnostics Launches Indiegogo Crowdfunding Campaign for DNA Medical Testing Device 2Cellgen Diagnostics Launches Indiegogo Crowdfunding Campaign for DNA Medical Testing Device 3As We Mourn Robin Williams’ Passing, His Death Sheds Light on Patients Struggling with Parkinson’s Disease 2As We Mourn Robin Williams’ Passing, His Death Sheds Light on Patients Struggling with Parkinson’s Disease 3Global Spectroscopy Equipment and Accessories - Strategic Business Report 2014 2Top Five Best Practices for Developing Your Periodic Benefit Risk Evaluation Report (PBRER), New Webinar Hosted by Xtalks 2
... EL SEGUNDO, Calif., July 27 NASA has exercised a ... continuing support to the Space Life Sciences Directorate at NASA,s Johnson ... The work will be done by Wyle,s Integrated Science and ... the bioastronautics contract, Wyle,s work supports the International Space Station, space ...
... , , , , ... Cardium Therapeutics (NYSE Amex: CXM ) ("Cardium") reported that ... that it had now resolved matters relating to the company,s exchange ... , In the communication from NYSE Amex, Cardium ...
... , , ... Pharmaceuticals, Inc. (NYSE-AMEX: NBY ) ( http://www.novabaypharma.com ), ... treatment or prevention of a wide range of bacterial, viral ... and Chief Executive Officer, will present at the Jesup & ...
Cached Biology Technology:NASA Extends Bioastronautics Contract With Wyle for Total Value of $976 Million 2Cardium Regains Listing Compliance with NYSE Amex 2Cardium Regains Listing Compliance with NYSE Amex 3NovaBay(R) Pharmaceuticals to Present at Jesup & Lamont 2009 Growth Stock Conference 2NovaBay(R) Pharmaceuticals to Present at Jesup & Lamont 2009 Growth Stock Conference 3
(Date:8/20/2014)... life can persist in a cold, dark world. A ... that examined waters and sediments from a shallow lake ... extreme environment supports microbial ecosystems. , The National ... has implications for life in other extreme environments, both ... are published in the current edition of the science ...
(Date:8/20/2014)... State University, the Wellcome Trust Sanger Institute and the ... Mycobacterium pinnipedii from skeletons found in Peru ... is a relative of the TB bacterium that affects ... These researchers assume that seals carried the pathogens from ... lions was unexpected" comments Sebastien Gagneux, from the Swiss ...
(Date:8/20/2014)... screening outcomes of approximately 3 million infants, a team ... the University of Massachusetts Medical School, have shown that ... successfully implemented across public health newborn screening programs. Data ... 20 issue of the Journal of the American ... of SCID in newborns is higher than previously thought ...
Breaking Biology News(10 mins):University of Tennessee research uncovers subglacial life beneath Antarctic ice sheet 2Newborn screening expansion offers early diagnosis and treatment to infants with SCID 2Newborn screening expansion offers early diagnosis and treatment to infants with SCID 3
... wily coyote reigns as top dog in much of the ... its larger relative, the wolf, according to a new study ... more than 30 percent lower in areas that they share ... edition of the Journal of Animal Ecology, details the results ...
... UCSF scientists are reporting what they say is a ... cells to their embryonic state, a process that transforms ... The finding, published on-line as an immediate early publication ... the strategic breakthrough reported by Shinya Yamanaka, MD, PhD, ...
... complex behaviour of primates can be understood using artificially-intelligent ... published in a special edition of Philosophical Transactions of ... Festival of Science in York. Scientists using ... some primate groups are despotic whilst others are egalitarian ...
Cached Biology News:Who's afraid of the big, bad wolf? Coyotes 2Embryonic stem cell strategy advanced with UCSF finding 2Embryonic stem cell strategy advanced with UCSF finding 3Embryonic stem cell strategy advanced with UCSF finding 4Primate behavior explained by computer 'agents' 2
Rabbit polyclonal to QKI...
... Introducing SilverSNAP Stain for Mass Spectrometry ... proteome, mass spectrometry (MS) has emerged as ... Silver staining of 2-D gels is now ... of procedures that leads ultimately to identification ...
... ammonium sulfate are compatible with thermostable enzymes ... and AmpliThem™™ DNA polymerases. You can significantly ... one experiment by adding your own enzyme, ... supplied with the kit. This capability is ...
... Kits without ammonium sulfate are compatible with ... as Taq and AmpliThem™™ DNA polymerases. You ... systems in one experiment by adding your ... the PreMixes supplied with the kit. This ...
Biology Products: